dextroamphetamine has been researched along with Dyskinesia, Drug-Induced in 18 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Personal or family tic history, medication selection, or dosage was not related to onset of T/D." | 1.29 | Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. ( Adesman, AR; Goldstein, IJ; Lipkin, PH, 1994) |
| "We conclude that phenytoin induced hyperkinesias reflect a specific effect of phenytoin on an abnormal neural substrate and suggest the presence of an otherwise silent pathological alteration of the corpus striatum." | 1.26 | Clinical and experimental studies of phenytoin-induced hyperkinesias. ( Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (55.56) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garg, V | 1 |
| Mahdavi, A | 1 |
| Raghavan, S | 1 |
| Yates, JR | 1 |
| Marusich, JA | 1 |
| Gipson, CD | 1 |
| Beckmann, JS | 1 |
| Bardo, MT | 1 |
| Kanes, SJ | 1 |
| Tokarczyk, J | 1 |
| Siegel, SJ | 1 |
| Bilker, W | 1 |
| Abel, T | 1 |
| Kelly, MP | 1 |
| Andersen, MB | 1 |
| Werge, T | 1 |
| Fink-Jensen, A | 1 |
| Nudelman, A | 1 |
| Gil-Ad, I | 1 |
| Shpaisman, N | 1 |
| Terasenko, I | 1 |
| Ron, H | 1 |
| Savitsky, K | 1 |
| Geffen, Y | 1 |
| Weizman, A | 1 |
| Rephaeli, A | 1 |
| Borison, RL | 1 |
| Diamond, BI | 1 |
| Schrader, G | 1 |
| Hicks, EP | 1 |
| Broekkamp, CL | 1 |
| Lipkin, PH | 1 |
| Goldstein, IJ | 1 |
| Adesman, AR | 1 |
| Cassady, SL | 1 |
| Adami, H | 1 |
| Moran, M | 1 |
| Kunkel, R | 1 |
| Thaker, GK | 1 |
| Carroll, BJ | 1 |
| Curtis, GC | 1 |
| Kokmen, E | 1 |
| Nausieda, PA | 3 |
| Koller, WC | 1 |
| Weiner, WJ | 3 |
| Klawans, HL | 3 |
| Goetz, C | 1 |
| Smith, RC | 1 |
| Tamminga, CA | 1 |
| Haraszti, J | 1 |
| Pandey, GN | 1 |
| Davis, JM | 1 |
| Pollock, J | 1 |
| Kornetsky, C | 1 |
| Weinstein, D | 1 |
| See, RE | 1 |
| Ellison, G | 1 |
| Korsgaard, S | 1 |
| Gerlach, J | 1 |
| Christensson, E | 1 |
1 trial available for dextroamphetamine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Spontaneous dyskinesia in subjects with schizophrenia spectrum personality.
Topics: Comorbidity; Dextroamphetamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind | 1998 |
17 other studies available for dextroamphetamine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Dexamphetamine abuse in an elderly man.
Topics: Aged; Alcoholism; Amphetamine-Related Disorders; Anxiety Disorders; Central Nervous System Stimulant | 2011 |
High impulsivity in rats predicts amphetamine conditioned place preference.
Topics: Amphetamine-Related Disorders; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Ani | 2012 |
Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acoustic Stimulation; Animals; Antipsychotic Agents; Behavior, | 2007 |
The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys.
Topics: Animals; Arousal; Behavior, Animal; Cebus; Cholinesterase Inhibitors; Dextroamphetamine; Dyskinesia, | 2007 |
A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Biological Availability; Catalepsy; Dextroamphe | 2008 |
Anticholinergics promote neuroleptic-induced tardive dyskinesia.
Topics: Amantadine; Animals; Antipsychotic Agents; Benztropine; Dextroamphetamine; Drug Synergism; Dyskinesi | 1980 |
Narcolepsy, paranoid psychosis, major depression, and tardive dyskinesia.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Dextroamphetamine; Dyskinesi | 1984 |
Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants.
Topics: Animals; Apomorphine; Cats; Dextroamphetamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Nom | 1982 |
Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Chronic Disease; | 1994 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamp | 1977 |
Clinical and experimental studies of phenytoin-induced hyperkinesias.
Topics: Aged; Animals; Apomorphine; Basal Ganglia; Corpus Striatum; Dextroamphetamine; Disease Models, Anima | 1979 |
The effect of lithium on an animal model of tardive dyskinesia.
Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Dyskinesia, Drug-Induced; Guinea Pi | 1977 |
Levodopa-induced dopamine receptor hypersensitivity.
Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Dyskinesia, Drug-Induced; Humans; L | 1977 |
Effects of dopamine agonists in tardive dyskinesia.
Topics: Administration, Oral; Apomorphine; Brain; Dextroamphetamine; Dopamine; Dyskinesia, Drug-Induced; Gro | 1977 |
Naloxone prevents and blocks the emergence of neuroleptic-mediated oral stereotypic behaviors.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Dyskinesia, Drug-Induced; Haloperidol; Male; Nalid | 1991 |
Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1989 |
Behavioral aspects of serotonin-dopamine interaction in the monkey.
Topics: Animals; Chlorocebus aethiops; Cyproheptadine; Dextroamphetamine; Dopamine; Dyskinesia, Drug-Induced | 1985 |